In vivo induction of myeloid suppressor cells and CD4 +foxp3 + T regulatory cells prolongs skin allograft survival in mice

D. Adeegbe, Paolo Serafini, V. Bronte, A. Zoso, Camillo Ricordi, Luca A Inverardi

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Natural CD4 +Foxp3 + T regulatory (Treg) cells can promote transplantation acceptance across major histocompatibility complex (MHC) barriers, while myeloid-derived suppressor cells (MDSCs) inhibit effector Tcell responses in tumor-bearing mice. One outstanding issue is whether combining the potent suppressive function of MDSCs with that of Treg cells might synergistically favor graft tolerance. In the present study, we evaluated the therapeutic potential of MDSCs and natural Treg cells in promoting allograft tolerance in mice by utilizing immunomodulatory agents to expand these cells in vivo. Upon administration of recombinant human granulocyte-colony stimulating factor (G-CSF; Neupogen), or interleukin-2 complex (IL-2C), Gr-1 +CD11b + MDSCs or CD4 +Foxp3 + Treg cells were respectively induced at a high frequency in the peripheral lymphoid compartments of treated mice. Interestingly, induced MDSCs exhibited a more potent suppressive function in vitro when compared to MDSCs from naive mice. Furthermore, in vivo coadministration of Neupogen and IL-2C induced MDSCs at percentages that were higher than those seen when either agent was administered alone, suggesting an additive effect of the two drugs. Although treatment with either IL- 2C or Neupogen led to a significant delay of MHC class II disparate allogeneic donor skin rejection, the combinatorial treatment was superior to either alone. Importantly, histological assessment of surviving grafts revealed intact morphology and minimal infiltrates at 60 days posttransplant. Collectively, our findings demonstrate that concurrent induction of MDSCs and Tregs is efficacious in downmodulating alloreactive T-cell responses in a synergistic manner and highlight the therapeutic potential of these naturally occurring suppressive leukocytes to promote transplantation tolerance.

Original languageEnglish
Pages (from-to)941-954
Number of pages14
JournalCell Transplantation
Volume20
Issue number6
DOIs
StatePublished - Aug 22 2011

Fingerprint

Regulatory T-Lymphocytes
Myeloid Cells
Allografts
Skin
Grafts
Bearings (structural)
Transplantation Tolerance
T-cells
Tumors
Granulocyte Colony-Stimulating Factor
Major Histocompatibility Complex
Interleukin-2
Myeloid-Derived Suppressor Cells
Therapeutics
Leukocytes
Transplantation
T-Lymphocytes
Transplants
Pharmaceutical Preparations
Filgrastim

Keywords

  • Myeloid-derived suppressor cells (MDSCs)
  • Suppression
  • Tolerance
  • Transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

In vivo induction of myeloid suppressor cells and CD4 +foxp3 + T regulatory cells prolongs skin allograft survival in mice. / Adeegbe, D.; Serafini, Paolo; Bronte, V.; Zoso, A.; Ricordi, Camillo; Inverardi, Luca A.

In: Cell Transplantation, Vol. 20, No. 6, 22.08.2011, p. 941-954.

Research output: Contribution to journalArticle

@article{31854bbea7064553a72465201c356c1e,
title = "In vivo induction of myeloid suppressor cells and CD4 +foxp3 + T regulatory cells prolongs skin allograft survival in mice",
abstract = "Natural CD4 +Foxp3 + T regulatory (Treg) cells can promote transplantation acceptance across major histocompatibility complex (MHC) barriers, while myeloid-derived suppressor cells (MDSCs) inhibit effector Tcell responses in tumor-bearing mice. One outstanding issue is whether combining the potent suppressive function of MDSCs with that of Treg cells might synergistically favor graft tolerance. In the present study, we evaluated the therapeutic potential of MDSCs and natural Treg cells in promoting allograft tolerance in mice by utilizing immunomodulatory agents to expand these cells in vivo. Upon administration of recombinant human granulocyte-colony stimulating factor (G-CSF; Neupogen), or interleukin-2 complex (IL-2C), Gr-1 +CD11b + MDSCs or CD4 +Foxp3 + Treg cells were respectively induced at a high frequency in the peripheral lymphoid compartments of treated mice. Interestingly, induced MDSCs exhibited a more potent suppressive function in vitro when compared to MDSCs from naive mice. Furthermore, in vivo coadministration of Neupogen and IL-2C induced MDSCs at percentages that were higher than those seen when either agent was administered alone, suggesting an additive effect of the two drugs. Although treatment with either IL- 2C or Neupogen led to a significant delay of MHC class II disparate allogeneic donor skin rejection, the combinatorial treatment was superior to either alone. Importantly, histological assessment of surviving grafts revealed intact morphology and minimal infiltrates at 60 days posttransplant. Collectively, our findings demonstrate that concurrent induction of MDSCs and Tregs is efficacious in downmodulating alloreactive T-cell responses in a synergistic manner and highlight the therapeutic potential of these naturally occurring suppressive leukocytes to promote transplantation tolerance.",
keywords = "Myeloid-derived suppressor cells (MDSCs), Suppression, Tolerance, Transplantation",
author = "D. Adeegbe and Paolo Serafini and V. Bronte and A. Zoso and Camillo Ricordi and Inverardi, {Luca A}",
year = "2011",
month = "8",
day = "22",
doi = "10.3727/096368910X540621",
language = "English",
volume = "20",
pages = "941--954",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "6",

}

TY - JOUR

T1 - In vivo induction of myeloid suppressor cells and CD4 +foxp3 + T regulatory cells prolongs skin allograft survival in mice

AU - Adeegbe, D.

AU - Serafini, Paolo

AU - Bronte, V.

AU - Zoso, A.

AU - Ricordi, Camillo

AU - Inverardi, Luca A

PY - 2011/8/22

Y1 - 2011/8/22

N2 - Natural CD4 +Foxp3 + T regulatory (Treg) cells can promote transplantation acceptance across major histocompatibility complex (MHC) barriers, while myeloid-derived suppressor cells (MDSCs) inhibit effector Tcell responses in tumor-bearing mice. One outstanding issue is whether combining the potent suppressive function of MDSCs with that of Treg cells might synergistically favor graft tolerance. In the present study, we evaluated the therapeutic potential of MDSCs and natural Treg cells in promoting allograft tolerance in mice by utilizing immunomodulatory agents to expand these cells in vivo. Upon administration of recombinant human granulocyte-colony stimulating factor (G-CSF; Neupogen), or interleukin-2 complex (IL-2C), Gr-1 +CD11b + MDSCs or CD4 +Foxp3 + Treg cells were respectively induced at a high frequency in the peripheral lymphoid compartments of treated mice. Interestingly, induced MDSCs exhibited a more potent suppressive function in vitro when compared to MDSCs from naive mice. Furthermore, in vivo coadministration of Neupogen and IL-2C induced MDSCs at percentages that were higher than those seen when either agent was administered alone, suggesting an additive effect of the two drugs. Although treatment with either IL- 2C or Neupogen led to a significant delay of MHC class II disparate allogeneic donor skin rejection, the combinatorial treatment was superior to either alone. Importantly, histological assessment of surviving grafts revealed intact morphology and minimal infiltrates at 60 days posttransplant. Collectively, our findings demonstrate that concurrent induction of MDSCs and Tregs is efficacious in downmodulating alloreactive T-cell responses in a synergistic manner and highlight the therapeutic potential of these naturally occurring suppressive leukocytes to promote transplantation tolerance.

AB - Natural CD4 +Foxp3 + T regulatory (Treg) cells can promote transplantation acceptance across major histocompatibility complex (MHC) barriers, while myeloid-derived suppressor cells (MDSCs) inhibit effector Tcell responses in tumor-bearing mice. One outstanding issue is whether combining the potent suppressive function of MDSCs with that of Treg cells might synergistically favor graft tolerance. In the present study, we evaluated the therapeutic potential of MDSCs and natural Treg cells in promoting allograft tolerance in mice by utilizing immunomodulatory agents to expand these cells in vivo. Upon administration of recombinant human granulocyte-colony stimulating factor (G-CSF; Neupogen), or interleukin-2 complex (IL-2C), Gr-1 +CD11b + MDSCs or CD4 +Foxp3 + Treg cells were respectively induced at a high frequency in the peripheral lymphoid compartments of treated mice. Interestingly, induced MDSCs exhibited a more potent suppressive function in vitro when compared to MDSCs from naive mice. Furthermore, in vivo coadministration of Neupogen and IL-2C induced MDSCs at percentages that were higher than those seen when either agent was administered alone, suggesting an additive effect of the two drugs. Although treatment with either IL- 2C or Neupogen led to a significant delay of MHC class II disparate allogeneic donor skin rejection, the combinatorial treatment was superior to either alone. Importantly, histological assessment of surviving grafts revealed intact morphology and minimal infiltrates at 60 days posttransplant. Collectively, our findings demonstrate that concurrent induction of MDSCs and Tregs is efficacious in downmodulating alloreactive T-cell responses in a synergistic manner and highlight the therapeutic potential of these naturally occurring suppressive leukocytes to promote transplantation tolerance.

KW - Myeloid-derived suppressor cells (MDSCs)

KW - Suppression

KW - Tolerance

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=80051777041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051777041&partnerID=8YFLogxK

U2 - 10.3727/096368910X540621

DO - 10.3727/096368910X540621

M3 - Article

C2 - 21054938

AN - SCOPUS:80051777041

VL - 20

SP - 941

EP - 954

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 6

ER -